The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Clinical trials sponsored by The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School, explained in plain language.
-
New hope for kids with spine paralysis: smaller surgery, faster recovery?
Disease control OngoingThis study tests a less invasive back surgery for children aged 6 to 20 who developed a curved spine and tilted pelvis after a spinal cord injury. The goal is to see if the smaller surgery can straighten the spine just as well as the standard large surgery, but with less blood lo…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
New combo drug may shrink fatty liver in diabetics
Disease control ENROLLING_BY_INVITATIONThis study compares two diabetes treatments—a combination drug (iGlarLixi) versus insulin alone—to see which better reduces liver fat in people with type 2 diabetes and fatty liver disease. About 36 participants will take the assigned medication for 12 weeks. The goal is to find …
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
Blood-Cleansing therapy tested on thousands of poisoning patients
Disease control OngoingThis study looks at whether treatments that filter the blood (like dialysis or plasma exchange) can help people survive acute poisoning. Researchers will compare patients who received these treatments to those who did not, using data from over 5,000 people aged 12 and older in Ch…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Diabetes pills may boost brain health in new trial
Disease control OngoingThis study tests whether three common diabetes medications—liraglutide, empagliflozin, and linagliptin—can help reverse mild cognitive impairment (early memory and thinking problems) in people with type 2 diabetes. About 396 adults aged 40 to 75 will take one of the drugs for 48 …
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Immune cell boost: new hope for advanced cancer?
Disease control OngoingThis early-phase trial tests a new immune cell therapy (memory NK cells) combined with standard treatment for people with advanced solid tumors that have spread. The main goal is to check safety in a small group of 6 patients. If safe, the study may expand to see if the therapy h…
Phase: PHASE1, PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Needle therapy may boost brain and mood in seniors with memory worries
Symptom relief OngoingThis study tests whether electroacupuncture (a type of acupuncture with mild electric pulses) can improve memory and mood in adults aged 60-80 who have subjective cognitive decline (noticing memory slips) along with depression. About 86 participants will receive either real or sh…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated May 26, 2026 03:28 UTC
-
Robots take on gallstones: safer for doctors, same for patients?
Symptom relief OngoingThis study compares a new robot-assisted endoscope to the standard method for removing gallstones from the bile duct. The goal is to see if the robot is as effective and safe, while also reducing radiation exposure and physical strain on doctors. About 200 adults with common bile…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
Stem cell eye drops offer new hope for dry eye sufferers
Symptom relief OngoingThis early-phase study tests whether stem cell eye drops can help people with dry eye disease who did not get better with standard artificial tears. Ten women aged 40-60 will use the drops twice daily for two weeks and be followed for three months. The study aims to see if the dr…
Phase: EARLY_PHASE1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated May 18, 2026 12:03 UTC
-
Blood test may predict organ damage in poisoning cases
Knowledge-focused OngoingThis study looks at 193 people who swallowed a toxic chemical called diquat. Researchers want to see if the amount of diquat in the blood can help predict which patients will have organ damage. The goal is to better understand how to identify high-risk patients early.
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC